SAFETY OF TRALOKINUMAB IN PAEDIATRIC PATIENTS AGED 12-17 WITH MODERATE-TO-SEVERE AROPIC DERMATITIS: RESULTS FROM THE PHASE 3 ECZTRA 6 TRIAL

被引：0

作者：

Wollenberg, Andreas ^{[1
,2
]}

Cork, Michael J. ^{[3
,4
]}

Flohr, Carsten ^{[5
,6
]}

Bewley, Anthony ^{[7
]}

Blauvelt, Andrew ^{[8
]}

Hong-H, Chih-Ho ^{[9
]}

Imafuku, Shinichi ^{[10
]}

Schuttelaar, Marie-Louise Anna ^{[11
]}

Simpson, Eric ^{[12
]}

Soong, Weily ^{[13
]}

Amoudruz, Petra ^{[14
]}

Lophaven, Katja ^{[14
]}

Kurbasic, Azra ^{[14
]}

Soldbro, Lise ^{[14
]}

Vest, Natacha ^{[14
]}

Paller, Amy ^{[15
]}

机构：

[1] Ludwig Maximilian Univ Munich, Dept Dermatol & Allergy, Munich, Germany

[2] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel UZ Brussel, Dept Dermatol, Brussels, Belgium

[3] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield Dermatol Res, Sheffield, S Yorkshire, England

[4] Sheffield Teaching Hosp, NIHR Clin Res Facil, Sheffield, S Yorkshire, England

[5] Guys St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dept Paediattol, St John, NF, Canada

[6] Kings Coll London, London, England

[7] Barts Hlth NHS Trust, London, England

[8] Oregon Med Res Ctr, Portland, OR USA

[9] Univ British Columbia, Vancouver, BC, Canada

[10] Fukuoka Univ, Fukuoka, Japan

[11] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands

[12] Oregon Hlth & Sci Univ, Portland, OR USA

[13] Allervie Hlth Alabama Allergy & Asthma Ctr, Birmingham, AL USA

[14] LEO Pharma AS, Ballerup, Denmark

[15] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P067

引用

页码：58 / 58

页数：1

共 50 条

[1] Laboratory parameters in adolescent patients aged 12-17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial
Paller, Amy
Cork, Michael
Hong, Chih-ho
Soong, Weily
Schneider, Shannon
Lo, Hannah
Pedersen, Line Rosendahl Meldgaard
Vacko, Emilia
Wollenberg, Andreas
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II47 - II48
[2] THE IMPACT OF TRALOKINUMAB ON QUALITY OF LIFE AND SCHOOL IN PATIENTS AGED 12-17 WITH ATOPIC DERMATITIS: RESULTS FROM THE PHASE 3 ECZTRA 6 TRIAL
Paller, Amy S.
Silverberg, Jonathan I.
Hong, Chih-ho
Cork, Michael J.
Puig, Luis
Amoudruz, Petra
Kurbasic, Azra
Soldbro, Lise
Simpson, Eric L.
[J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 51 - 52
[3] Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial
Paller, Amy
Blauvelt, Andrew
Soong, Weily
Imafuku, Shinichi
Hong, Chih-Ho
Schuttelaar, Marie L. A.
Amoudruz, Petra
Kurbasic, Azra
Soldbro, Lise
Lophaven, Katja
Cork, Michael
Bewley, Anthony
Simpson, Eric L.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E90 - E91
[4] Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial
Paller, A.
Blauvelt, A.
Soong, W.
Imafuku, S.
Hong, C.
Schuttelaar, M. L. A.
Amoudruz, P.
Kurbasic, A.
Soldbro, L.
Lophaven, K.
Schneider, S.
Cork, M.
Bewley, A.
Simpson, E. L.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E145 - E146
[5] CONJUNCTIVITIS IN ADOLESCENT PATIENTS AGED 12-17 WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS TREATED WITH TRALO-KINUMAB UP TO WEEK 52: RESULTS FROM THE PHASE 3 ECZTRA 6 TRIAL
Wollenberg, Andreas
de Bruin-Weller, Marjolein S.
Thyssen, Jacob P.
Beck, Lisa A.
Simpson, Eric L.
Imafuku, Shinichi
Boguniewicz, Mark
Kurbasic, Azra
Soldbro, Lise
Vest, Natacha Strange
Amoudruz, Petra
Paller, Amy S.
[J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 35 - 35
[6] Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis The Phase 3 ECZTRA 6 Randomized Clinical Trial
Paller, Amy S.
Flohr, Carsten
Cork, Michael
Bewley, Anthony
Blauvelt, Andrew
Hong, H. Chih-ho
Imafuku, Shinichi
Schuttelaar, Marie L. A.
Simpson, Eric L.
Soong, Weily
Arlert, Petra
Lophaven, Katja Wendicke
Kurbasic, Azra
Soldbro, Lise
Vest, Natacha Strange
Wollenberg, Andreas
[J]. JAMA DERMATOLOGY, 2023, 159 (06) : 596 - 605
[7] USE OF TOPICAL CORTICOSTEROIDS WITH TRALOKINUMAB IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM THE 32-WEEK, PHASE 3 ECZTRA 3 TRIAL
Silverberg, Jonathan I.
Pink, Andrew E.
Kurbasic, Azra
Olsen, Christina Kurre
Weidinger, Stephan
[J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 55 - 55
[8] Efficacy and safety of tralokinumab monotherapy in North American adult patients with moderate-to-severe atopic dermatitis: A subanalysis of the ECZTRA 2 trial
Wiseman, Marni
Armstrong, April W.
Soung, Jennifer
Albrecht, Lorne
Lomaga, Mark
Papp, Kim A.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB178 - AB178
[9] Tralokinumab prevents flares in moderate-to-severe atopic dermatitis: post hoc analyses of a randomized phase III clinical trial (ECZTRA 3)
Silverberg, J. I.
Barbarot, S.
Welzel, J.
Ameen, M.
Thyssen, J. P.
Lomaga, M.
Olsen, C. Kurre
Mark, T.
Corriveau, J.
Merola, J. F.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E79 - E79
[10] EFFICACY AND SAFETY OF TRALOKINUMAB IN A KOREAN SUBPOPULATION OF PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A SUBANALYSIS OF ECZTRA 2, A PHASE 3, MONOTHERAPY, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL
Kim, Kyu Han
Son, Sang Wook
Lee, Yang Won
Simpson, Eric L.
Kuznetsova, Alexandra
Cho, Sang Hyun
[J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 63 - 63

← 1 2 3 4 5 →